A Study to Evaluate a New Silicone Hydrogel Contact Lens
- Conditions
- Myopia
- Registration Number
- NCT01309893
- Lead Sponsor
- Bausch & Lomb Incorporated
- Brief Summary
The objective of this study is to determine the clinical feasibility and to evaluate the product performance of investigational contact lenses.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 66
- Have physiologically normal anterior segments not exhibiting clinically significant biomicroscopy findings.
- Be myopic and require lens correction from -0.50 D to -5.50 D in each eye.
- Any systemic disease affecting ocular health.
- Using any systemic or topical medications that will affect ocular physiology or lens performance.
- An active ocular disease, any corneal infiltrative response or are using any ocular medications.
- Any "Present" finding during the slit lamp examination that, in the Investigator's judgment, interferes with contact lens wear.
- Allergic to any component in the study care products.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Primary Outcome Measures
Name Time Method Distance High Contrast logMAR Visual Acuity at 1 Week Baseline & 1 week Mean difference in distance high contrast logMAR over all lens VAs (visual acuity) from Baseline and 1 Week
- Secondary Outcome Measures
Name Time Method Overall Comfort 1 week Comfort measured by participant on a scale of 0-100 with 100 being the most favorable.
Slit Lamp Findings ≥ Grade 2 1 week Slit lamp findings are measured on a scale of 0-4, where 0=none, and 4=severe. The slit lamp exam is a routine procedure done to evaluate eye health and determine eligibility for clinical trial. It provides view of the different parts of the eye. During the exam, a doctor can look at the front parts of the eye, including the cornea, the lens, the iris and other parts of the anterior segment of the eye. Fluorescein dye may be used during a slit lamp examination to make it easier to detect inflammation, infections, or injured area on the cornea.
Trial Locations
- Locations (1)
Bausch & Lomb
🇺🇸Rochester, New York, United States
Bausch & Lomb🇺🇸Rochester, New York, United States